Who We Are

Apexray Biotech is a boutique international pharmaceutical consulting and business development firm focused on cross-border dealmaking. We specialize in API, Finished Dosage Forms, CDMO/CMO partnerships, and both licensing-out and licensing-in opportunities for generic, 505(b)(2) and clinical-stage new drug.

We work with API manufacturers, finished dosage form pharmaceutical companies, CDMOs/CMOs and biotech firms across Asia, Japan, Europe and North America, providing practical, hands-on BD support rather than generic advisory slides. Our role is to act as your external BD arm for complex international opportunities – from identifying the right partners to preparing, negotiating and closing commercially meaningful deals.